Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
F-18-Fluorodeoxyglucose positron emission tomography (F-18-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer
F-18-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis
F-18-Fluoroethyl-L-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging
F-18-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications
F-18-FDG uptake and clearance in patients with compromised renal function
F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers
F-18 FDG PET/CT versus CT/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma
F-18-FDG PET/CT in a case of primary hepatic adenosquamous carcinoma
F-18-FDG PET/CT in gastric lymphoepithelioma-like carcinoma
F-18-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer
F-18-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer
F-18-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma
F-18-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients
F-18-FDG PET/CT imaging in systemic lupus erythematosus related autoimmune haemolytic anaemia and lymphadenopathy
F-18-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis
F-18-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors
F-18-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients
F-18-FDG PET/CT Imaging of Burkitt Lymphoma Presenting With Unusual Muscle Involvement
F-18-Labeled Benzyldiamine Derivatives as Novel Flexible Probes for Positron Emission Tomography of Cerebral beta-Amyloid Plaques
F-18-FDG PET/CT of Adrenal Lesions
F-18-FLT and F-18-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats
F-18-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer
F-18-Fallypride PET of Pancreatic Islets: In Vitro and In Vivo Rodent Studies
F-18-FLT and F-18-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours
F-18-FDG PET/CT as a Diagnostic Tool in Patients with Extracervical Carcinoma of Unknown Primary Site: A Literature Review
F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer
F-18-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer
F-18-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal Mesothelioma
F-18 fluorodeoxyglucose uptake in gastric adenoma after stomach distention by water
F-18 FDG PET/CT Provides the Earliest Findings of Enthesitis in Reactive Arthritis
F-18 Flurodeoxyglucose Negative, F-18 Fluoride Accumulating in a Brain Metastasis in a Treated Case of Carcinoma of the Breast
F-18-FDG PET-CT scanning and diabetic patients: what to do?
F-18-FDG PET imaging analysis for computer aided Alzheimer's diagnosis
F-18-fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma
F-18-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
F-18-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer
F-18-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT
F-18-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different
F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer
F-18-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma
F-18 FDG PET/CT Imaging of Solitary Genital Tuberculosis Mimicking Recurrent Lymphoma
F-18 FDG PET/CT in Evaluation of Pulmonary Sclerosing Hemangioma
F-18 Labeled Nanoparticles for in Vivo PET-CT Imaging
F-18-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
F-18 FDG PET/CT Findings in a Case of Gastric Relapse of Acute Myeloblastic Leukemia
F-18-fluorodeoxyglucose Uptake on Positron Emission Tomography as a Prognostic Predictor in Locally Advanced Hepatocellular Carcinoma
F-18-Fluorodeoxyglucose and PET/CT for noninvasive study of exercise-induced glucose uptake in rat skeletal muscle and tendon
F-18-FDG PET as a Monitoring Tool to Assess Treatment Response in Bilateral Adrenal Histoplasmosis
F-18-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results
F-18-FPPRGD2 PET/CT: Pilot Phase Evaluation of Breast Cancer Patients
F-18-fluorodeoxyglucose Positron Emission Tomography and Magnetic Resonance Imaging Findings of Primary Intracranial Histiocytic Sarcoma in a Dog
F-18-FDG and C-11-MET Positron Emission Tomography Findings of Cutaneous Mast Cell Tumor in a Dog
F-18-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma
F-18-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go